Geode Capital Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.1M | Buy |
|
|||||
|
2025
Q1 | $31M | Buy |
|
|||||
|
2024
Q4 | $44.5M | Buy |
|
|||||
|
2024
Q3 | $49.9M | Sell |
|
|||||
|
2024
Q2 | $31.5M | Buy |
|
|||||
|
2024
Q1 | $38.8M | Buy |
|
|||||
|
2023
Q4 | $22.4M | Buy |
|
|||||
|
2023
Q3 | $11.6M | Buy |
|
|||||
|
2023
Q2 | $18.4M | Buy |
|
|||||
|
2023
Q1 | $23.1M | Buy |
|
|||||
|
2022
Q4 | $18.6M | Buy |
|
|||||
|
2022
Q3 | $15.3M | Buy |
|
|||||
|
2022
Q2 | $13.3M | Buy |
|
|||||
|
2022
Q1 | $26.4M | Buy |
|
|||||
|
2021
Q4 | $39.4M | Buy |
|
|||||
|
2021
Q3 | $35.2M | Buy |
|
|||||
|
2021
Q2 | $16.6M | Buy |
|
|||||
|
2021
Q1 | $7.25M | Sell |
|
|||||
|
2020
Q4 | $11.9M | Buy |
|
|||||
|
2020
Q3 | $1.17M | Buy |
|